ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,490Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 1187

$1.7M Total Retail Price of All Prescriptions

Rank: 6 out of 1187

690 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 690 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 690 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 21,541 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 1,146 1,030 1 8
WARFARIN SODIUM 854 750 2 13
LEVOTHYROXINE SODIUM 777 661 3 3
AMLODIPINE BESYLATE 766 663 4 2
METOPROLOL TARTRATE 674 562 5 10
SIMVASTATIN 605 531 6 1
LISINOPRIL 552 468 7 4
PRAVASTATIN SODIUM 490 437 8 12
OMEPRAZOLE 447 385 9 5
CITALOPRAM HBR 408 352 10 45
ATORVASTATIN CALCIUM 405 369 11 6
RISPERIDONE 380 339 12 58
MIRTAZAPINE 354 341 13 54
METFORMIN HCL 348 293 14 7
SERTRALINE HCL 310 278 15 22
DONEPEZIL HCL 306 306 16 26
GABAPENTIN 304 256 17 23
PRANDIN 299 244 18 139
LEVETIRACETAM 289 170 19 89
ACETAMINOPHEN-CODEINE 281 230 S3 20 105
ISOSORBIDE MONONITRATE ER 274 247 21 66
HYDROCHLOROTHIAZIDE 261 213 22 9
LOSARTAN POTASSIUM 255 236 23 21
CARVEDILOL 242 222 24 19
METOPROLOL SUCCINATE 222 204 25 11
NAMENDA 217 217 26 44
KLOR-CON M20 217 188 26 93
TRAZODONE HCL 205 143 28 63
CLOPIDOGREL 202 193 29 33
NOVOLOG FLEXPEN 198 169 30 171
POTASSIUM CHLORIDE 195 177 31 32
LANTUS 194 185 32 77
FAMOTIDINE 183 159 33 48
TRICOR 175 157 34 94
OXYCODONE-ACETAMINOPHEN 167 138 S2 35 47
CRESTOR 160 144 36 16
PLAVIX 156 149 37 52
ESCITALOPRAM OXALATE 156 111 37 51
DIVALPROEX SODIUM 153 110 39 79
TRAMADOL HCL-ACETAMINOPHEN 151 131 40 102
RANITIDINE HCL 147 122 41 69
PREDNISONE 141 106 42 61
ENALAPRIL MALEATE 139 114 43 27
ZOLPIDEM TARTRATE 132 118 44 14
PANTOPRAZOLE SODIUM 131 117 45 42
METOCLOPRAMIDE HCL 128 103 46 159
QUETIAPINE FUMARATE 128 56 46 75
NEXIUM 125 109 48 15
ADVAIR DISKUS 125 83 48 35
LEVOFLOXACIN 124 107 50 74
ALENDRONATE SODIUM 124 121 50 25
LACTULOSE 116 77 52 96
RAMIPRIL 116 89 52 36
IPRATROPIUM-ALBUTEROL 116 86 52 109
POLYETHYLENE GLYCOL 3350 111 92 55 86
GLIMEPIRIDE 109 109 56 30
CLONIDINE HCL 108 97 57 73
COUMADIN 106 106 58 237
DIOVAN 105 103 59 17
FLOVENT HFA 102 102 60 216
ATENOLOL 102 98 60 18
AZITHROMYCIN 101 92 62 24
NYSTATIN-TRIAMCINOLONE 99 97 63 208
CALCITONIN-SALMON 99 99 63 278
SPS 98 77 65 282
DIGOXIN 98 87 65 65
TOPIRAMATE 98 29 65 161
MUPIROCIN 96 86 68 127
SPIRIVA 93 89 69 55
SSD 93 84 69 331
OLANZAPINE 92 62 71 107
CIPROFLOXACIN HCL 91 75 72 84
TAMSULOSIN HCL 90 75 73 29
LEVEMIR FLEXPEN 90 62 73 188
AMIODARONE HCL 89 89 75 205
ARANESP 89 89 75 333
LIPITOR 85 76 77 43
FENTANYL 85 83 S2 77 82
ALLOPURINOL 84 78 79 50
COLCRYS 84 81 79 223
MEGESTROL ACETATE 83 81 R 81 185
CARBIDOPA-LEVODOPA 81 70 82 99
NYSTOP 78 40 83 294
NITROGLYCERIN PATCH 76 76 84 138
HYDROXYZINE HCL 75 54 R 85 231
NYSTATIN 74 42 86 123
ZETIA 72 65 87 64
AMLODIPINE BESYLATE-BENAZEPRIL 71 51 88 62
PROAIR HFA 71 50 88 41
HYDRALAZINE HCL 70 63 90 113
SANTYL 69 68 91 150
PAROXETINE HCL 68 60 92 81
NOVOLOG 67 57 93 135
CEFUROXIME 67 64 93 130
FENOFIBRATE 67 58 93 88
GLYBURIDE 66 54 R 96 90
TRAMADOL HCL 66 66 96 28
COMBIVENT 66 53 96 219
ABILIFY 65 45 99 155
PHENYTOIN SODIUM EXTENDED 64 39 100 173
ATROVENT HFA 62 57 101 302
ROPINIROLE HCL 62 60 101 180
BUPROPION HCL SR 61 30 103 368
BETAMETHASONE DIPROPIONATE 61 0 103 193
CYMBALTA 57 56 105 60
FLUOXETINE HCL 57 27 105 108
QUINAPRIL HCL 56 56 107 106
BACLOFEN 56 29 107 148
FINASTERIDE 55 54 109 110
SINGULAIR 54 47 110 67
OXYBUTYNIN CHLORIDE ER 54 44 110 118
SILVER SULFADIAZINE 53 49 112 322
TRAVATAN Z 52 43 113 221
LIDODERM 52 38 113 80
IBANDRONATE SODIUM 52 50 113 191
XIFAXAN 50 0 116 306
ERYTHROMYCIN 50 25 116 326
ACTOS 50 47 116 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.